Status | Study |
Recruiting |
Study Name: Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma Condition: Adult Nasal Type Extranodal NK/T-Cell Lymphoma Adult T-Cell Leukemia/Lymphoma Date: 2016-01-08 Interventions: Other: Laboratory Biomarker Analysis |
Recruiting |
Study Name: CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL Condition: Peripheral T-Cell Lymphoma Angioimmunoblastic T Cell Lymphoma Date: 2015-07-18 Interventions: Drug: CEOP/IVE/GDP chemotherapy regimen |
Recruiting |
Study Name: Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency Condition: Aggressive Non-Hodgkin Lymphoma Anaplastic Large Cell Lymphoma Date: 2013-02-06 Interventions: Dietary Supplement: Cholecalciferol |
Recruiting |
Study Name: CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma Condition: ALK-negative Anaplastic Large Cell Lymphoma Peripherial T Cell Lymphoma,Not Otherwise Specif Date: 2012-12-04 Interventions: Drug: Cyclophosphamide 750mg/m2 |
Active, not recruiting |
Study Name: Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab in T- and NK-Cell Lymphomas Condition: T-Cell Peripheral Lymphoma Gamma Delta Hepatosplenic T-Cell Lymphoma Date: 2011-09-30 Interventions: Biological: Rituximab Rituxima |
Terminated |
Study Name: Prospective Study of Functional and Quality of Life Outcomes in Panniculectomy Patients Condition: Panniculitis Date: 2010-08-09 Interventions: Procedure: panniculectomy surgery |
Recruiting |
Study Name: T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma Condition: Lymphoma, T-Cell, Peripheral Date: 2010-06-10 |
Terminated |
Study Name: Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory Lymphoma Condition: 714leukemia Lymphoma Date: 2008-05-02 Interventions: Drug: Bortezomib |
Completed |
Study Name: Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies Condition: Relapsed or Refractory Lymphoproliferative Malignancies Hodgkin's Lymphoma Date: 2007-06-01 Interventions: Drug: Pralatrexate Injection |